Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non‐invasive diagnosis and surveillance of bladder cancer with driver and passenger DNA methylation in a prospective cohort study
Yu Xiao, Lingao Ju, Kaiyu Qian, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 8
Open Access | Times Cited: 22

Showing 22 citing articles:

Current and Future Role of Circulating DNA in the Diagnosis and Management of Urothelial Carcinoma
Joaquim Bellmunt, Brian M. Russell, Bernadett Szabados, et al.
American Society of Clinical Oncology Educational Book (2025) Vol. 45, Iss. 2
Closed Access
Epigenetic and Immunological Features of Bladder Cancer
I. R. Gilyazova, Kadriia Enikeeva, Guzel Rafikova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9854-9854
Open Access | Times Cited: 15
New Perspectives on the Role of Liquid Biopsy in Bladder Cancer: Applicability to Precision Medicine
Fernardo Alberca-del Arco, Juan Daniel Prieto Cuadra, Rocío Santos-Pérez DE LA Blanca, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 803-803
Open Access | Times Cited: 3
Urine‐based liquid biopsy in bladder cancer: Opportunities and challenges
Gang Wang, Wan Jin, Zilin Xu, et al.
Clinical and Translational Discovery (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 9
Liquid biopsy in urothelial carcinoma: Detection techniques and clinical applications
Siyu Wu, Rong Li, Yuan‐Hong Jiang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115027-115027
Open Access | Times Cited: 9
Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysis
Zhouting Tuo, Dechao Feng, Zhiwei Jiang, et al.
Chinese Journal of Cancer Research (2023) Vol. 35, Iss. 6, pp. 686-701
Open Access | Times Cited: 9
Hypermethylation Loci of ZNF671, IRF8, and OTX1 as Potential Urine-Based Predictive Biomarkers for Bladder Cancer
Yuan‐Hong Jiang, Yushu Liu, Yu‐Chung Wei, et al.
Diagnostics (2024) Vol. 14, Iss. 5, pp. 468-468
Open Access | Times Cited: 2
MIR145 Core Promoter Methylation in Pretreatment Cell-Free DNA: A Liquid Biopsy Tool for Muscle-Invasive Bladder Cancer Treatment Outcome
Katerina‐Marina Pilala, Georgios Kotronopoulos, Panagiotis Levis, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 2
The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples
Hongwei Peng, Ming Pan, Zongning Zhou, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1
Relationship between clonal evolution and drug resistance in bladder cancer: A genomic research review
Zhouting Tuo, Ying Zhang, Dengxiong Li, et al.
Pharmacological Research (2024) Vol. 206, pp. 107302-107302
Open Access | Times Cited: 1
Concurrent DNA hypomethylation and epigenomic reprogramming driven by androgen receptor binding in bladder cancer oncogenesis
Yu Xiao, Lingao Ju, Jin Wan, et al.
Clinical and Translational Medicine (2024) Vol. 15, Iss. 1
Closed Access | Times Cited: 1
DUSP2 affects bladder cancer prognosis by down-regulating MEK/ERK and P38 MAPK signaling pathways through PTPN7
Fan Zou, Ting Rao, Chen Wu, et al.
Cellular Signalling (2023) Vol. 112, pp. 110893-110893
Closed Access | Times Cited: 4
Brain Tumor Classification by Methylation Profile
Jin Woo Park, Kwanghoon Lee, Eric Eunshik Kim, et al.
Journal of Korean Medical Science (2023) Vol. 38, Iss. 43
Open Access | Times Cited: 2
A universal molecular mechanism driving aging
Jin Wan, Jing Zheng, Yu Xiao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Research Progress of New Urine Markers in the Diagnosis of Bladder Cancer
Rose Lamichhane
annals of urologic oncology (2024)
Open Access
From Detection to Cure – Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder Cancer
Joshua A. Linscott, Hiroko Miyagi, Prithvi Murthy, et al.
Current Oncology Reports (2024)
Closed Access
Determination of global DNA methylation level by methylation-sensitive comet assay in patients with urinary bladder cancer
Ozer Kocak, Selin Kankaya, Göktuğ Kalender, et al.
Mutagenesis (2024) Vol. 39, Iss. 6, pp. 280-286
Closed Access
Circulating tumor DNA methylation detection as biomarker and its application in tumor liquid biopsy: advances and challenges
Lingyu Li, Yingli Sun
MedComm (2024) Vol. 5, Iss. 11
Open Access
Urine‐Based Biomarkers

(2024), pp. 787-817
Closed Access
Novel Urinary Liquid Biopsy Biomarkers and Their Role in Detecting Genitourinary Cancers
Blake Salfer, Feng Li, Yazhen Zhu, et al.
Journal of Clinical and Translational Pathology (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 1
Urinary Tumor DNA-Based Diagnosis and Surveillance for Nonmuscle-Invasive Bladder Cancer—Current Landscape and Future Directions
Alexander L. Shiang, Cayce Nawaf, Pradeep S. Chauhan, et al.
Société Internationale d’Urologie Journal (2023) Vol. 4, Iss. 4, pp. 301-307
Open Access
Page 1

Scroll to top